This PDF is the current document as it appeared on Public Inspection on 02/18/2014 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Human Tissue Intended for Transplantation” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, PRAStaff@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
On December 20, 2013, the Agency submitted a proposed collection of information entitled “Human Tissue Intended for Transplantation” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0302. The approval expires on January 31, 2017. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.Start Signature
Dated: February 12, 2014.
Assistant Commissioner for Policy.
[FR Doc. 2014-03502 Filed 2-18-14; 8:45 am]
BILLING CODE 4160-01-P